Highest-materiality recent filing
Crescent BDC Q2 2026 NII $0.36/sh, net loss $0.09/sh; regular dividend cut to $0.34
Net investment income per share $0.36, down from $0.42 in Q1 and $0.46 in Q2 2025; net loss $(0.09) vs +$0.41 year-ago.
Net investment income of $15.5M ($0.42/share) vs $16.5M ($0.45) prior quarter; net loss of ($15.5M) or ($0.42)/share.
Crescent Capital BDC closes $135M senior notes issuance; swaps to floating rate
Issued $67.5M Tranche A notes at 5.87% due Feb 2029 and $67.5M Tranche B notes at 6.20% due Feb 2031.
Crescent BDC Q4 NII $0.45, full-year $1.81; NAV $19.10; Q1 dividend $0.42
Full-year net investment income $66.9M, or $1.81 per share, down from $2.40 in 2024.
Crescent Capital BDC Reports Q3 2025 Net Investment Income of $0.46 Per Share
Net investment income per share $0.46 for Q3 2025, down from $0.64 in Q3 2024.
Crescent Capital BDC reports Q2 2025 net investment income of $0.46 per share, NAV $19.55
Net investment income for Q2 2025 was $0.46 per share, including $0.02 of one-time accelerated amortization
Crescent BDC Q1 NII $0.45/sh; NAV down to $19.62; declares $0.42 base dividend
Net investment income of $0.45 per share; net income of $0.11 per share for Q1 2025.
Crescent Capital BDC Q4 NII $0.55/shr; declares $0.42 base plus $0.15 special dividends
Q4 2024 net investment income $0.55/shr; net income $0.27/shr; NAV per share $19.98 (down from $20.20 prior qtr).
NII per share $0.64 (up from $0.59 Q3 2023); net income $0.41 vs $0.61 a year ago.
Crescent Capital BDC Q2 NII $0.59/sh, NAV $20.30; declares $0.42 base + $0.09 supplemental dividend
Net investment income per share $0.59 (up from $0.56 YoY); net income per share $0.55.
Crescent Capital BDC Q1 NII $0.63/share; NAV $20.28; raises quarterly dividend by $0.01
Net investment income of $0.63/share vs $0.54/share in Q1 2023; net income $0.76/share.
Crescent Capital BDC Q4 net investment income $0.61/sh; NAV $20.04; appoints Henry Chung President
Q4 net investment income $0.61/share ($22.8M) vs $0.52/share YoY; net income $0.83/share.
Net investment income of $21.7 million ($0.59 per share) for quarter ended September 30, 2023, up from $0.56 in prior quarter.
Net investment income of $20.6M ($0.56 per share) vs $0.50 per share in Q2 2022.
Crescent Capital BDC Q1 NII $0.54/share; NAV $19.38; completed First Eagle BDC acquisition
Net investment income $17.5M ($0.54/share) vs. $0.52 prior quarter and $0.39 year-ago quarter.
Crescent BDC has no cash accounts, deposits, or credit facilities with Silicon Valley Bank or Signature Bank.
Crescent Capital BDC completes merger with First Eagle BDC; combined assets >$1.6B
FCRD stockholders received $0.29 cash, 0.20635 CCAP shares, and $1.17 transaction support per share.
Crescent BDC Q3 NII $0.52/share, NAV $20.16; declares $0.41 dividend; appoints new CCO
Net investment income of $16.0M ($0.52/share); adjusted NII $13.0M ($0.42/share).
Crescent Capital BDC to acquire First Eagle Alternative Capital BDC in stock/cash deal
Combined company expected to have ~$1.6B of investments on a pro forma basis.
Crescent Capital BDC Q2 NII $0.50/share vs $0.39 prior; declares $0.41 regular dividend
Net investment income of $15.5M ($0.50/share) up from $12.1M ($0.39/share) in Q1 2022; adjusted NII $12.7M ($0.41/share).
Crescent Capital BDC ups revolving credit facility to $350M from $300M
Credit facility increased by $50M to $350M under amendment dated March 4, 2022.
Crescent BDC reports Q3 NII $0.45/sh, declares $0.41 regular + $0.05 special dividends
Net investment income $12.7M ($0.45/sh); Adjusted NII $13.5M ($0.48/sh).
Crescent Capital BDC enters $300M revolving credit facility, terminates Ally Bank facility
New $300 million senior secured revolving credit facility with Sumitomo Mitsui Banking Corporation as admin agent and lender.
Crescent Capital BDC Q2 NII $0.39/share; declares $0.41 Q3 dividend
Net investment income $11.0M ($0.39/share); adjusted NII $14.8M ($0.53/share).
On and effective as of 12:00 a.m. midnight on May 5, 2026, the Board of Directors (the “Board”) of Crescent Capital BDC, Inc. (the “Company”) accepted the resignation of Elizabeth Ko as a member of the Board and a Class III Director.
On and effective as of 1:00 p.m. on May 7, 2026, the Board elected Mr. Jason Breaux as a Class III director, which is the class of directors that will stand for election at the Company’s 2027 Annual Meeting of Stockholders, or until a successor is duly elected and qualified.
On and effective as of 1:00 p.m. on May 7, 2026, the Board elected Mr. Henry Chung as a Class III director, which is the class of directors that will stand for election at the Company’s 2027 Annual Meeting of Stockholders, or until a successor is duly elected and qualified.
Mr. Chung succeeds Jason Breaux as the Company’s President. Mr. Breaux continues in his role as the Company’s Chief Executive Officer.
Effective February 15, 2024, the Board of Directors of the Company appointed Henry Chung, age 36, as its President.
Additionally, as of the Effective Date, the Board appointed Erik Barrios as the Company's Chief Compliance Officer.
On and effective as of November 4, 2022 (the "Effective Date"), the Board of Directors (the "Board") of Crescent Capital BDC, Inc. (the "Company") accepted the resignation of Joe Hanlon as the Chief Compliance Officer.
appointed Susan Yun Lee as an independent Class II director to fill the vacancy created by such increase.
the Board elected Ms. Elizabeth E. Ko as a Class III director, which is the class of directors that will stand for election at the Company’s 2024 Annual Meeting of Stockholders, or until a successor is duly elected and qualified. Ms. Ko, who will serve as Chairman of the Board
the Board appointed Jason A. Breaux as the Company’s President.
the Board of Directors (the “Board”) of Crescent Capital BDC, Inc. (the “Company”) accepted the resignation of Christopher G. Wright as a member of the Board.
Max materiality 0.85 · Median 0.55 · Most common event earnings